d-Allulose and erythritol increase butyrate production and impact the gut microbiota in healthy adults and adults with type-2 diabetes ex vivo
Beneficial Microbes · 2025
DOI: 10.1163/18762891-bja00071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beneficial Microbes, 2025. Verfasst von K Adolphus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tate & Lyle PLC, 5 Marble Arch, London W1H 7EJ, UK. Hauptthemen laut MEDLINE: Erythritol, Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Butyrates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tate & Lyle PLC.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type-2 diabetes mellitus (T2DM) is associated with a reduction of butyrate-producing gut bacteria. d -allulose and erythritol are low-no-calorie sweeteners (LNCS) used as sugar substitutes to reduce high free sugar intakes associated with non-communicable diseases, including T2DM. This is the first study to investigate the impact of representative and physiologically relevant doses of d -allulose and erythritol on the human gut microbiota of T2DM ( ) and co-living healthy adults ( ). Using the clinically predictive ex vivo SIFR® technology, d -allulose and erythritol were shown to significantly increase butyrate production 24–48 h after treatment and significantly increased the abundance of particular microbial families or species in both healthy individuals and those with T2DM compared to the no-substrate control (NSC). d-A llulose significantly increased the abundance of Anaerostipes hadrus and Lachnospiraceae_unclassified_species ( ) at 48 h in healthy adults and adults with T2DM compared to the NSC. Erythritol significantly increased the abundance of Eubacteriaceae and Barnesiellaceae families at 48 h in healthy adults and adults with T2DM but had no significant effects on microbial species compared to the NSC. d -Allulose resulted in a larger increase in butyrate between 6-24 h whereas erythritol resulted in a larger increased butyrate between 24–48 h. The findings suggest prebiotic potential of d -allulose and erythritol worth of investigation in human clinical trials, as blending d -allulose and erythritol could be a promising strategy to reduce free sugar intakes and increase butyrate production in both healthy and T2DM individuals, resulting in beneficial effects on glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tate & Lyle PLC, 5 Marble Arch, London W1H 7EJ, UK.
- Cryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.
Förderung
- Tate & Lyle PLC
Zitieren
APA
Adolphus, K., Van den Abbeele, P., Poppe, J., Deyaert, S., Baudot, A., Laurie, I., Karnik, K., & Risso, D. (2025). d-Allulose and erythritol increase butyrate production and impact the gut microbiota in healthy adults and adults with type-2 diabetes ex vivo. Beneficial Microbes. https://doi.org/10.1163/18762891-bja00071
Vancouver
Adolphus K, Van den Abbeele P, Poppe J, Deyaert S, Baudot A, Laurie I, et al. d-Allulose and erythritol increase butyrate production and impact the gut microbiota in healthy adults and adults with type-2 diabetes ex vivo. Beneficial Microbes. 2025. doi:10.1163/18762891-bja00071
BibTeX
@article{Adolphus2025,
author = {Adolphus, K and Van den Abbeele, P and Poppe, J and Deyaert, S and Baudot, A and Laurie, I and Karnik, K and Risso, D},
title = {d-Allulose and erythritol increase butyrate production and impact the gut microbiota in healthy adults and adults with type-2 diabetes ex vivo},
journal = {Beneficial Microbes},
year = {2025},
doi = {10.1163/18762891-bja00071}
}
EUVIMED